Sansure Presents Future of Pathogen Identification and Disease Diagnosis

Sansure is introducing Surelite – its first CE-IVDR-certified automated CLIA system. The Surelite 8 and Surelite 16 are compact automated CLIA systems that deliver rapid and accurate diagnostic results in as fast as 15 minutes. The smart design, featuring an all-in-one cartridge and a broad spectrum of assays, matches various clinical demands with no extra consumables and no waste. Visitors to the Sansure booth at Medlab Middle East 2024 can also experience the iPonatic III Portable Molecular Workstation alongside the Q-POC Platform. iPonatic III, born in the age of the pandemic, is now finding application in the diagnosis of various infections, including respiratory tract infection (RTI), sexually transmitted infection (STI), and more. On the other hand, the Q-POC Platform is a molecular diagnosis instrument that offers accurate PCR results within 25 minutes. The multiple target points facilitate the testing and evaluation of severe and critical cases.

At Medlab Middle East 2024, Sansure is highlighting its high-throughput, high-precision extraction systems which enable a complete workflow of sample preprocessing and nucleic acid extraction. The Natch CS2 fully automated nucleic acid extraction system is a powerful nucleic acid purification system with an extremely simple workflow. Similarly, the Natch 48 nucleic acid extraction system with advanced magnetic bead technology makes it easy to operate this automatic nucleic acid extractor. Among other products on display at the show is the MA-6000 real-time fluorescence quantitative PCR system equipped with innovative hardware, structure, and optimized software to deliver higher-quality results. MA-6000 ensures extraordinary detection sensitivity, extends the application of thermal cycler from nucleic acid to biotinylated protein, and expands a brand new path for multiplex diagnosis in the clinical field.

Related Links:
Sansure Biotech